Mineralocorticoid receptor mediates heart failure in the 11ß-hydroxysteroid dehydrogenase type 2 transgenic mouse model

被引：0
作者：
Qin, WN
Bond, BR
Donoho, GP
Heyen, JR
Frierdich, GE
Bolten, CW
Funder, JW
McMahon, EG
机构：
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Pfizer Inc, St Louis, MO USA
[3] Pfizer Inc, Kalamazoo, MI USA
[4] Pfizer Inc, La Jolla, CA USA
[5] Prince Henrys Inst Med Res, Melbourne, Vic, Australia
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2946
引用
收藏
页码：634 / 634
页数：1
相关论文
共 50 条
  • [21] Expression of mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type II in renal cell neoplasms:: A tissue microarray study
    Yakirevich, E.
    Morris, D. J.
    Tavares, R.
    Leehpammer, M.
    Wang, L. J.
    Sabo, E.
    DeLellis, R. A.
    Resnick, M. B.
    [J]. LABORATORY INVESTIGATION, 2007, 87 : 184A - 184A
  • [22] Expression of mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type II in cutaneous adnexal neoplasms:: A tissue microarray study
    Laga, A. C.
    Yakirevich, E.
    Morris, D. J.
    Tavares, R.
    Noble, L.
    DeLellis, R. A.
    Resnick, M. B.
    [J]. MODERN PATHOLOGY, 2008, 21 : 96A - 96A
  • [23] Expression of mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type II in cutaneous adnexal neoplasms:: A tissue microarray study
    Laga, A. C.
    Yakirevich, E.
    Morris, D. J.
    Tavares, R.
    Noble, L.
    DeLellis, R. A.
    Resnick, M. B.
    [J]. LABORATORY INVESTIGATION, 2008, 88 : 96A - 96A
  • [24] Expression of mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type II in renal cell neoplasms:: A tissue microarray study
    Yakirevich, E.
    Morris, D. J.
    Tavares, R.
    Lechpammer, M.
    Wang, L. J.
    Sabo, E.
    DeLellis, R. A.
    Resnick, M. B.
    [J]. MODERN PATHOLOGY, 2007, 20 : 184A - 184A
  • [25] LOCALIZATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR
    EDWARDS, CRW
    BURT, D
    MCINTYRE, MA
    DEKLOET, ER
    STEWART, PM
    BRETT, L
    SUTANTO, WS
    MONDER, C
    [J]. LANCET, 1988, 2 (8618) : 986 - 989
  • [26] Two homozygous mutations in the 11β-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess
    Carvajal, CA
    Gonzalez, AA
    Romero, DG
    González, A
    Mosso, LM
    Lagos, ET
    Hevia, MD
    Rosati, MP
    Perez-Acle, TO
    Gomez-Sanchez, CE
    Montero, JA
    Fardella, CE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) : 2501 - 2507
  • [27] A mutation in the cofactor-binding domain of 11β-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertensions
    Odermatt, A
    Dick, B
    Arnold, P
    Zaehner, T
    Plueschke, V
    Deregibus, MN
    Repetto, H
    Frey, BM
    Frey, FJ
    Ferrari, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) : 1247 - 1252
  • [28] Impaired protein stability of 11β-hydroxysteroid dehydrogenase type 2:: A novel mechanism of apparent mineralocorticoid excess
    Atanasov, Atanas G.
    Ignatova, Irena D.
    Nashev, Lyubomir G.
    Dick, Bernhard
    Ferrari, Paolo
    Frey, Felix J.
    Odermatt, Alex
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (04): : 1262 - 1270
  • [29] Two elderly patients with mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) impairment
    Inada, Mitsuo
    Iwasaki, Keiko
    Imai, Chihiro
    Hashimoto, Satoshi
    [J]. INTERNAL MEDICINE, 2008, 47 (07) : 631 - 636
  • [30] Reduced brain 11β-hydroxysteroid dehydrogenase type 2 activity contributes to sympathetic excitation in heart failure rats
    Zhang, ZH
    Yu, Y
    Wei, SG
    Kang, YM
    Felder, RB
    [J]. CIRCULATION, 2005, 112 (17) : U133 - U133
12345